Stryker's stock surged 5.57% during Friday's intraday trading session following the company's optimistic financial updates.

The medical device maker raised its adjusted full-year earnings per share forecast to a range of $14.90 to $15.10, significantly higher than its previous guidance of $13.50 to $13.60. Additionally, Stryker reported better-than-expected results for the fourth quarter, exceeding analyst estimates for both adjusted profit and revenue.

The upbeat earnings report prompted positive reactions from analysts, with several brokerages raising their price targets on the stock. CEO Kevin Lobo noted an increased tariff impact projection for the year, but investors focused on the strengthened profit outlook, driving the share price higher.